The company is developing innovative devices for the measurement of reliable pulse oximetry (non-invasive oxygen saturation or "SpO2") under low perfusion (poor blood circulation) and signal interference (patient motion) conditions . The Company was founded in 2000, but technicians have specialized career in this filed more than 20 years. Key target markets for the Company's products vary widely from ICU segments to the hospital at a wide range of point-of-care testing sites at the hospital, medical clinic, long-term care, emergency and of public health regulation.

KTMED offers market-leading solutions in the field of patient monitor system.

Grouped quotes (0)